Iplex weill never be produced again, and the deniers of reality
That comment came from someone who had a close relationship with the drug and it's promise.You dont have to believe it, but realistic investors know dang well the drug was dropped and 11 M rights deal was the end.Any biotech experienced investor knows that if Iplex had the sort of potential the clowns post here the drug would be trialed and produced.MONEY trumps everything in bios.Shires foray is clinical at this point. Failures to produce investment worthy results in diabetes HARS and numerous others was proof to realistic investors .The 2018 Yes! is fodder.Insmed is a totally different co than 4++ years ago.Iplex is not ever mentioned after the rop deal.
Robert (and all these ids lux zippy insm to 25 dorain) is the sort of shareholder that should never be in bios.
why didn't the company do an ALS trial as was asked by the FDA? why did they sell the mfg and release the rights to ROP?...you should have dealt with the loss years ago. Your average is $ 1.00 to $1.31 if you have been a long. ignore on during trading hours..ah such comic relief- )
Those that got the sugar pill did better than those that got the drug,” Robert P. Charrow, an attorney for Insmed, told U.S. District Judge Thomas J. McAvoy during a hearing. ...and you wonder why we call them the clowns! Surfs up! YTD I am 110% profits in INSM out now and amused.
Well if you say it then it must be true. Yeah right. Not saying you're wrong, but c'mon man, you have zero credibility on this board after all the #$%$ you've posted that has been wrong. When Lewis says it, then I'll believe it, until then, save your breath, shorty.